Holen Sie sich die Stockscreener-App
15.55
0.45%
0.07
Vorhandelsmarkt:
15.55
Uniqure N V Aktie (QURE) Neueste Nachrichten
uniQure N.V. Facing Inflection Point in Trend AnalysisJuly 2025 Trends & AI Enhanced Execution Alerts - beatles.ru
Short Term Trend Reversal in uniQure N.V. PossibleJuly 2025 Fed Impact & Free High Accuracy Swing Entry Alerts - 선데이타임즈
What to expect from uniQure N.V. in the next 30 daysTrade Volume Report & Consistent Return Strategy Ideas - Newser
Visual analytics tools that track uniQure N.V. performanceJuly 2025 Breakouts & AI Powered Market Trend Analysis - Newser
Smart tools for monitoring uniQure N.V.’s price actionWeekly Trade Review & Free Technical Confirmation Trade Alerts - Newser
Using fundamentals and technicals on uniQure N.V.Market Activity Recap & Entry Point Confirmation Signals - Newser
How to use Fibonacci retracement on uniQure N.V.Quarterly Portfolio Report & Long-Term Growth Portfolio Plans - Newser
uniQure N.V’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
Momentum divergence signals in uniQure N.V. chart2025 Market Trends & Fast Entry High Yield Stock Tips - Newser
How uniQure N.V. stock performs during market volatilityBull Run & Real-Time Chart Breakout Alerts - Newser
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
UniQure Shares Rise After Mizuho Upgrade - MarketScreener
Mizuho Securities Upgrades UniQure NV(QURE.US) to Buy Rating, Announces Target Price $30 - 富途牛牛
uniQure stock rating upgraded by Mizuho on Huntington’s disease therapy potential - Investing.com
How sentiment analysis helps forecast uniQure N.V.ROI Focused Setup Screener With Exit Markers - Newser
uniQure N.V. stock trend outlook and recovery pathPortfolio Review Summary with Five-Year Outlook - Newser
Will uniQure N.V. price bounce be sustainableWeekly Breakout Forecast with Entry Zones - Newser
Institutional Ownership Dominates uniQure N.V., Hedge Funds Hold 19% - AInvest
uniQure N.V. (NASDAQ:QURE) is favoured by institutional owners who hold 55% of the company - uk.finance.yahoo.com
Uniqure N.V. shares rise 1.04% after-hours following PTC Therapeutics' positive Q2 earnings report. - AInvest
Aberdeen Group Expands Stake in uniQure with Strategic Acquisition - AInvest
Aberdeen Group plc Expands Stake in uniQure NV with Strategic Ac - GuruFocus
How high can uniQure N.V. stock price go in 2025AI Powered Buy Point Forecast Planner - Newser
uniQure (NASDAQ:QURE) Stock Rating Upgraded by Wall Street Zen - Defense World
Is uniQure N.V. a good long term investmentGet exclusive access to premium stock research - Jammu Links News
What is uniQure N.V. company’s growth strategyStrongest growth potential - Jammu Links News
Should I hold or sell uniQure N.V. stock in 2025Unlock daily market insights for better trades - Jammu Links News
What makes uniQure N.V. stock price move sharplyBuild a strong portfolio for long-term success - Jammu Links News
What drives uniQure N.V. stock priceUnprecedented market success - Jammu Links News
Is uniQure N.V. a growth stock or a value stockMaximize returns with disciplined investment techniques - Jammu Links News
What is the risk reward ratio of investing in uniQure N.V. stockOutstanding growth strategies - Jammu Links News
What are the latest earnings results for uniQure N.V.Discover undervalued stocks before they soar - Jammu Links News
How does uniQure N.V. compare to its industry peersMaximize your gains with expert trading tips - Jammu Links News
Is uniQure N.V. stock overvalued or undervaluedDiscover high-impact stocks for your portfolio - Jammu Links News
What analysts say about uniQure N.V. stockDiscover breakthrough stocks before the crowd - Jammu Links News
How strong is uniQure N.V. company’s balance sheetBuild wealth faster with professional insights - Jammu Links News
What are the technical indicators suggesting about uniQure N.V.High-octane gains - Jammu Links News
What is HC Wainwright’s Forecast for uniQure Q3 Earnings? - Defense World
Why is uniQure N.V. stock attracting strong analyst attentionEntry Signal Signals To Watch Now - Jammu Links News
UniQure N.V. (NASDAQ:QURE) Just Released Its Second-Quarter Earnings: Here's What Analysts Think - 富途牛牛
A Quick Look at Today's Ratings for UniQure NV(QURE.US), With a Forecast Between $35 to $35 - 富途牛牛
uniQure Reports Q2 2025 Progress and Financials - TipRanks
uniQure’s AMT-130 Gene Therapy for Huntington’s Disease on Track for Q1 2026 BLA Submission After FDA Alignment - Insider Monkey
Huntington’s Disease Market to Expand Significantly by 2034, States DelveInsight Report | Prilenia Therapeutics, Neurocrine Biosciences, Som Biotech, Annexon Biosciences, Vaccinex, Sage Therapeutics - Barchart.com
Wall Street Analysts Think uniQure (QURE) Could Surge 142.67%: Read This Before Placing a Bet - Zacks Investment Research
uniQure N.V. (NASDAQ:QURE) Q2 2025 Earnings Call Transcript - Insider Monkey
1.55%
0.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):